Donor‐Derived Cell‐Free DNA for Diagnosing Subclinical Rejection: A Pilot Multicenter Study in Japanese Living‐Donor Kidney Transplantation
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70221 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Toshihito Hirai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Living Donors, Graft Rejection, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: JSPS KAKENHI, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Donor‐derived cell‐free DNA (dd‐cfDNA) offers a non‐invasive biomarker for detecting allograft injury. However, its performance in predominantly living‐donor transplant settings in Asian populations remains underexplored.
Methods
In a multicenter prospective pilot study, 73 living‐donor kidney transplant (LKT) recipients from Japan underwent plasma dd‐cfDNA testing and protocol biopsies approximately 1 year post‐transplant. Diagnostic performance of dd‐cfDNA for subclinical antibody‐mediated rejection (AMR) was evaluated at 1.0% and 0.5% cut‐off thresholds.
Results
Eight patients (11.0%) were diagnosed with subclinical active AMR. Patients with dd‐cfDNA ≥1.0% showed significantly higher incidence of AMR compared to those with dd‐cfDNA
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
- Yocho-machi Clinic, Tokyo, Japan.
- Department of Organ Transplant Medicine, Tokyo Women's Medical University Hospital, Tokyo, Japan.
- Department of Urology, Toda Central General Hospital, Saitama, Japan.
- Department of Nephrology, Shonan Kamakura General Hospital, Kamakura, Japan.
- Department of Urology, Yachiyo Medical Center, Tokyo Women's Medical University, Chiba, Japan.
ORCID-Profile: Toshihito Hirai, Sumi Hidaka, Kohei Unagami
Förderung
- JSPS KAKENHI
- Japan Society for the Promotion of Science
Zitieren
APA
Hirai, T., Banno, T., Omoto, K., Shimizu, T., Hidaka, S., Kijima, Y., Furusawa, M., Saitoh, A., Unagami, K., Inui, M., Ishida, H., & Takagi, T. (2025). Donor‐Derived Cell‐Free DNA for Diagnosing Subclinical Rejection: A Pilot Multicenter Study in Japanese Living‐Donor Kidney Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70221
Vancouver
Hirai T, Banno T, Omoto K, Shimizu T, Hidaka S, Kijima Y, et al. Donor‐Derived Cell‐Free DNA for Diagnosing Subclinical Rejection: A Pilot Multicenter Study in Japanese Living‐Donor Kidney Transplantation. Clinical Transplantation. 2025. doi:10.1111/ctr.70221
BibTeX
@article{Hirai2025,
author = {Hirai, Toshihito and Banno, Taro and Omoto, Kazuya and Shimizu, Tomokazu and Hidaka, Sumi and Kijima, Yu and Furusawa, Miyuki and Saitoh, Ayaka and Unagami, Kohei and Inui, Masashi and Ishida, Hideki and Takagi, Toshio},
title = {Donor‐Derived Cell‐Free DNA for Diagnosing Subclinical Rejection: A Pilot Multicenter Study in Japanese Living‐Donor Kidney Transplantation},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70221}
}
EUVIMED